ERBB2 and breast carcinoma: In transgenic mouse models of mammary carcinoma, driven by Erbb2 and polyomavirus middle T-ag (PyMT), germline Akt1 gene ablation inhibited primary tumor development and, although increased tumor invasiveness, it did not increase the risk of metastasis.